Pilot Study for Patients With Chemotherapy Resistant or Refractory CD19 Leukemia and Lymphoma (CART-19)

Sponsor and Collaborators     
University of Pennsylvania

Contact
David Porter, MD         
trpctu@mail.med.upenn.edu


Continue Reading

Investigator
David Porter, MD     
University of Pennsylvania

ClinicalTrials.gov Identifier
NCT00891215